KHN Morning Briefing

Summaries of health policy coverage from major news organizations

Brand-Name And Generic Drug Makers Join Forces To Challege FTC

Politico: Brand-Name, Generic Drugmakers Fight FTC
Brand and generic drug companies are usually at each other' throats. But they will stand shoulder to shoulder against the Federal Trade Commission and other health care interests come March 25, when the Supreme Court will hear oral arguments about a controversial way of settling patent disputes that’s worth billions to the drug industry (Norman, 3/12).

This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.